Literature DB >> 8120389

Redirection of T cell-mediated cytotoxicity by a recombinant single-chain Fv molecule.

A J George1, J A Titus, C R Jost, I Kurucz, P Perez, S M Andrew, P J Nicholls, J S Huston, D M Segal.   

Abstract

We have produced two single-chain Fv (sFv) proteins by bacterial periplasmic secretion, one sFv with specificity for the hapten DNP, and the other for the human transferrin receptor. After solubilization and refolding, we recovered several mg of active sFv per liter of bacterial culture. Each sFv bound to cells bearing the appropriate Ag and could be used to direct targeted cellular cytotoxicity. Targeting relied on a universal bispecific antibody designed to cross-link CD3 on the cytotoxic T cell with a peptide fused to the sFv carboxyl-terminus. The universal bispecific antibody was used in combination with the Ag-specific sFv to redirect human cytotoxic T cells to kill a variety of target cells. Such an approach has a number of advantages that may make it useful for the immunotherapy of cancer and other diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8120389

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

2.  Symmetry of Fv architecture is conducive to grafting a second antibody binding site in the Fv region.

Authors:  P C Keck; J S Huston
Journal:  Biophys J       Date:  1996-10       Impact factor: 4.033

3.  Selection of antibodies to cell surface determinants on mouse thymic epithelial cells using a phage display library.

Authors:  D B Palmer; A J George; M A Ritter
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

Review 4.  Engineering recombinant antibodies for immunotherapy.

Authors:  D Neri; H Petrul; G Roncucci
Journal:  Cell Biophys       Date:  1995-08

Review 5.  Redirection of cellular cytotoxicity. A two-step approach using recombinant single-chain Fv molecules.

Authors:  A J George; J A Titus; C R Jost; I Kurucz; P Perez; S M Andrew; P J Nicholls; J S Huston; D M Segal
Journal:  Cell Biophys       Date:  1995-06

6.  Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.

Authors:  A J George; F Jamar; M S Tai; B T Heelan; G P Adams; J E McCartney; L L Houston; L M Weiner; H Oppermann; A M Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

7.  Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis.

Authors:  I Miyajima; D Dombrowicz; T R Martin; J V Ravetch; J P Kinet; S J Galli
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

8.  Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains.

Authors:  D Dombrowicz; V Flamand; I Miyajima; J V Ravetch; S J Galli; J P Kinet
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

9.  Development of a novel bi-specific monoclonal antibody approach for tumour targeting.

Authors:  A A Koumarianou; M Hudson; R Williams; A A Epenetos; G W Stamp
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.